Isovaleric Acidemia (IVA) Treatment Global Market Report 2025
상품코드:1760583
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
이소길초산혈증(IVA) 치료 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 예측 기간을 살펴보면, 유전자 치료 접근 방식의 채택 증가, 희귀 질환 연구에 대한 투자 증가, 새로운 치료 옵션 파이프라인의 증가, 생명공학 회사와 연구 기관 간의 더 많은 협력 등이 IVA 치료의 성장을 견인할 것으로 예상됩니다. IVA와 같은 대사 장애에 대한 맞춤형 의학에 대한 강조도 증가하고 있습니다. IVA 치료의 장래를 형성할 것으로 보이는 주요 동향에는 유전자 검사 기술의 진보, 대사 치료제의 혁신적인 약물 전달 시스템, 효소 보충 제제의 개선, 표적 유전자 편집 툴 개발, 신생아 스크리닝 수법의 발전 등이 있습니다.이런 동향은 치료 효과를 향상시켜, 보다 이용하기 쉽게 할 가능성을 갖고 있어 IVA 환자의 관리와 결과의 개선에 희망을 주는 것입니다.
대사성 질환의 유병률 증가는 이소길초산혈증(IVA) 치료 시장의 성장을 가속할 것으로 예측됩니다. 정상적인 신진 대사 과정을 방해하고 신체에서 음식을 에너지로 변환하는 방법에 영향을 미칩니다. 이러한 질환의 유병률은 주로 식습관 저하와 신체 활동 부족과 같은 생활 습관 관련 요인으로 인해 증가하고 있으며, 이는 비만 및 인슐린 저항성과 같은 질환으로 이어집니다. 이소길초산혈증의 치료는 체내에 축적된 유해 물질에 대처해, 정상적인 대사 기능의 회복을 돕고, 신경장애 등의 합병증을 예방합니다. 미국 당뇨병 협회에 따르면, 미국에서는 2022년에 약 2,550만명이 당뇨병으로 진단되었고 인구의 7.6%를 차지했습니다.
희귀 유전성 질환에 대한 인식 증가는 IVA 치료 시장의 성장을 가속할 것으로 예측됩니다. 유전자 돌연변이로 인한 희귀 유전 질환은 종종 소수의 개인에게 영향을 미치지만, 진단 기술과 유전자 검사 프로그램의 발전으로 인해 점점 더 눈에 띄게 되고 있습니다. 이 개선으로, 보다 조기 그리고 정확한 발견이 가능해져, 이러한 질환의 보다 좋은 관리에 연결되고 있습니다. 특히 독성 대사산물의 축적을 줄이고 대사 위기를 예방하기 위해 전문적인 식이 요법, 아미노산 보충제, 때로는 약물을 제공함으로써 이러한 희귀 유전 질환을 해결합니다. 라디 어린이 병원에서 실시한 연구에 따르면 유아 사망의 41%가 단일 유전자좌(멘델리안) 유전 질환으로 인한 것으로 나타났습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장의 거시경제 시나리오 : 금리, 인플레이션, 지정학, 무역 전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 이소길초산혈증(IVA) 치료 시장 : PESTEL 분석(정치적, 사회적, 기술적, 환경적 및 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 이소길초산혈증(IVA) 치료 시장 : 성장률 분석
세계의 이소길초산혈증(IVA) 치료 시장 규모 및 성장률 : 실적치, 2019-2024년
세계의 이소길초산혈증(IVA) 치료 시장 규모 및 성장률 : 예측치, 2024-2029년, 2034년
세계의 이소길초산혈증(IVA) 치료 시장 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 이소길초산혈증(IVA) 치료 시장 : 유형별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
고전적 이소길초산혈증
중등도 이소길초산혈증
비고전적 이소길초산혈증
세계의 이소길초산혈증(IVA) 치료 시장 : 치료법별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
식사 관리
효소 보충 요법
유전자 치료
약물 치료
세계의 이소길초산혈증(IVA) 치료 시장 : 투여 경로별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
경구제
주사제
세계의 이소길초산혈증(IVA) 치료 시장 : 최종 사용자별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
병원
클리닉
재택치료
세계의 이소길초산혈증(IVA) 치료 시장(고전적 이소길초산혈증) : 유형별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
식사 관리
카르니틴 보충제
글리신 보충제
긴급관리
유전자 치료(치험)
세계의 이소길초산혈증(IVA) 치료 시장(비고전적 이소길초산혈증) : 유형별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
관찰과 예방 케어
경도의 식생활의 변경
가끔 보급
유전 상담과 모니터링
세계의 이소길초산혈증(IVA) 치료 시장(중등도 이소길초산혈증) : 유형별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
단백질 제한식
간헐적 카르니틴/글리신 요법
정기적인 모니터링과 지지요법
급성 발작 관리
제7장 지역별/국가별 분석
세계의 이소길초산혈증(IVA) 치료 시장 : 지역별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
세계의 이소길초산혈증(IVA) 치료 시장 : 국가별, 세분화, 역사 및 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
이소길초산혈증(IVA) 치료 시장 : 경쟁 구도
이소길초산혈증(IVA) 치료 시장 : 기업 프로파일
Nestle Health Science SA(개요, 제품 및 서비스, 전략, 재무 분석)
BioMarin Pharmaceutical Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
GenScript Biotech Corporation(개요, 제품 및 서비스, 전략, 재무 분석)
Nutricia Advanced Medical Nutrition(개요, 제품 및 서비스, 전략, 재무 분석)
Rocket Pharmaceuticals Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업 및 혁신 기업
REGENXBIO Inc.
uniQure NV
Vitaflo International Ltd.
Orchard Therapeutics plc
Editas Medicine Inc.
Cambrooke Therapeutics Inc.
Recordati Rare Diseases Inc.
Abbott Nutrition
Targeted Medical Pharma Inc.
Solace Nutrition LLC
Nutricia Metabolics
Bluebird Bio Inc.
Verve Therapeutics Inc.
Abeona Therapeutics Inc.
CRISPR Therapeutics AG
제32장 세계 시장 : 경쟁 벤치마킹 대시보드
제33장 주요 기업 합병 및 인수(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가 및 부문과 전략
이소길초산혈증(IVA) 치료 시장 : 최신 기회를 제공하는 국가(2029년)
이소길초산혈증(IVA) 치료 시장 : 최신 기회를 제공하는 부문(2029년)
이소길초산혈증(IVA) 치료 시장 : 성장 전략(2029년)
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Isovaleric acidemia (IVA) treatment involves managing a rare inherited metabolic disorder caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase, resulting in the buildup of isovaleric acid in the body. The goal of treatment is to decrease the accumulation of toxic substances and prevent metabolic crises.
The primary types of IVA treatment are classical isovaleric acidemia, moderate isovaleric acidemia, and non-classical isovaleric acidemia. Classical IVA is a severe metabolic disorder caused by the deficiency of isovaleryl-CoA dehydrogenase, which plays a crucial role in metabolizing the amino acid leucine. Treatments for IVA include dietary management, enzyme replacement therapy, gene therapy, and pharmacological interventions. These treatments are administered either orally or through injections and are provided in various settings, such as hospitals, clinics, and home care environments.
The isovaleric acidemia (IVA) treatment market research report is one of a series of new reports from The Business Research Company that provides isovaleric acidemia (IVA) treatment market statistics, including the isovaleric acidemia (IVA) treatment industry global market size, regional shares, competitors with the isovaleric acidemia (IVA) treatment market share, detailed isovaleric acidemia (IVA) treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the isovaleric acidemia (IVA) treatment industry. This isovaleric acidemia (IVA) treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The isovaleric acidemia (IVA) treatment market size has grown strongly in recent years. It will grow from $0.60 billion in 2024 to $0.63 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period of isovaleric acidemia (IVA) treatment can be attributed to awareness of rare metabolic disorders, expansion of newborn screening programs aiding early diagnosis, growing government funding for orphan diseases, focus on enzyme replacement therapies, and rising demand for early diagnosis and genetic counseling. These efforts have improved IVA detection and management, leading to better patient outcomes.
The isovaleric acidemia (IVA) treatment market size is expected to see strong growth in the next few years. It will grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. Looking to the forecast period, the growth of IVA treatment is expected to be driven by the increasing adoption of gene therapy approaches, rising investments in rare disease research, a growing pipeline of novel treatment options, and more collaborations between biotech firms and research institutions. There's also a rising emphasis on personalized medicine, particularly for metabolic disorders such as IVA. Major trends that are likely to shape the future of IVA treatment include advancements in genetic testing technologies, innovative drug delivery systems for metabolic therapies, improvements in enzyme replacement formulations, the development of targeted gene editing tools, and progress in newborn screening methodologies. These trends have the potential to improve the effectiveness of treatments and make them more accessible, offering hope for better management and outcomes for patients with IVA.
The increasing prevalence of metabolic disorders is expected to propel the growth of the isovaleric acidemia (IVA) treatment market. Metabolic disorders, such as diabetes mellitus, hypothyroidism, hyperthyroidism, and isovaleric acidemia (IVA), disrupt normal metabolic processes and affect how the body converts food into energy. The prevalence of these disorders is rising, primarily due to lifestyle-related factors such as poor diet and physical inactivity, leading to conditions such as obesity and insulin resistance. Isovaleric acidemia treatment addresses the buildup of toxic substances in the body, helping to restore normal metabolic function and preventing complications such as neurological damage. For example, according to the American Diabetes Association, approximately 25.5 million people in the U.S. were diagnosed with diabetes in 2022, accounting for 7.6% of the population. This increasing prevalence of metabolic disorders is driving the growth of the IVA treatment market.
The growing awareness of rare genetic disorders is also expected to propel the growth of the IVA treatment market. Rare genetic disorders, caused by mutations in genes, often affect a small number of individuals but are becoming more visible due to advancements in diagnostic technologies and genetic screening programs. These improvements allow for earlier and more accurate detection, leading to better management of these conditions. Isovaleric acidemia treatment specifically addresses this rare genetic disorder by offering specialized dietary regimens, amino acid supplementation, and sometimes medications to reduce the buildup of toxic metabolites and prevent metabolic crises. In February 2023, the World Health Organization reported that birth abnormalities, including conditions such as heart defects and neural tube defects, contribute to thousands of deaths annually. Additionally, a study conducted at Rady Children's Hospital revealed that 41% of infant deaths were due to single-locus (Mendelian) genetic diseases. These findings underscore the importance of raising awareness and improving diagnosis for rare genetic disorders, further fueling the growth of the IVA treatment market.
The rising adoption of personalized medicine is also driving the growth of the IVA treatment market. Personalized medicine, which tailors treatment based on individual characteristics such as genetics, lifestyle, and environment, is increasingly prevalent due to advancements in genetic testing and biomarker research. In the case of isovaleric acidemia, personalized medicine involves utilizing genetic insights to customize dietary and pharmacological interventions based on an individual's metabolic profile. This approach enhances treatment outcomes and reduces complications. For instance, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022, according to the Personalized Medicine Coalition. As personalized healthcare continues to evolve, the growth of the IVA treatment market is expected to accelerate, driven by the need for tailored therapies that improve patient outcomes.
Major players in the isovaleric acidemia (iva) treatment market are Nestle Health Science S.A., BioMarin Pharmaceutical Inc., GenScript Biotech Corporation, Nutricia Advanced Medical Nutrition, Rocket Pharmaceuticals Inc., REGENXBIO Inc., uniQure N.V., Vitaflo International Ltd., Orchard Therapeutics plc, Editas Medicine Inc., Cambrooke Therapeutics Inc., Recordati Rare Diseases Inc., Abbott Nutrition, Targeted Medical Pharma Inc., Solace Nutrition LLC, Nutricia Metabolics, Bluebird Bio Inc., Verve Therapeutics Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG.
North America was the largest region in the isovaleric acidemia (IVA) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in isovaleric acidemia (IVA) treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the isovaleric acidemia (IVA) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The isovaleric acidemia (IVA) treatment market consists of revenues earned by entities by providing services such as newborn screening programs, monitoring, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The isovaleric acidemia (IVA) treatment market includes sales of anticatabolic agents, L-carnitine supplements, and amino acid supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Isovaleric Acidemia (IVA) Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on isovaleric acidemia (iva) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for isovaleric acidemia (iva) treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isovaleric acidemia (iva) treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Isovaleric Acidemia (IVA) Treatment Market Trends And Strategies
4. Isovaleric Acidemia (IVA) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Isovaleric Acidemia (IVA) Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Isovaleric Acidemia (IVA) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Isovaleric Acidemia (IVA) Treatment Market Growth Rate Analysis
5.4. Global Isovaleric Acidemia (IVA) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Isovaleric Acidemia (IVA) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Isovaleric Acidemia (IVA) Treatment Total Addressable Market (TAM)
6.1. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Classical Isovaleric Acidemia
Moderate Isovaleric Acidemia
Non-classical Isovaleric Acidemia
6.2. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dietary Management
Enzyme Replacement Therapy
Gene Therapy
Pharmacological Treatment
6.3. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
6.4. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare Settings
6.5. Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dietary Management
Carnitine Supplementation
Glycine Supplementation
Emergency Management
Gene Therapy (Investigational)
6.6. Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Non-classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Observation and Preventive Care
Mild Dietary Modifications
Occasional Supplementation
Genetic Counseling and Monitoring
6.7. Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Moderate Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein-restricted Diet
Intermittent Carnitine/Glycine Therapy
Periodic Monitoring and Supportive Care
Acute Episode Management
7. Isovaleric Acidemia (IVA) Treatment Market Regional And Country Analysis
7.1. Global Isovaleric Acidemia (IVA) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Isovaleric Acidemia (IVA) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Isovaleric Acidemia (IVA) Treatment Market
9.1. China Isovaleric Acidemia (IVA) Treatment Market Overview
9.2. China Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Isovaleric Acidemia (IVA) Treatment Market
10.1. India Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Isovaleric Acidemia (IVA) Treatment Market
11.1. Japan Isovaleric Acidemia (IVA) Treatment Market Overview
11.2. Japan Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Isovaleric Acidemia (IVA) Treatment Market
12.1. Australia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Isovaleric Acidemia (IVA) Treatment Market
13.1. Indonesia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Isovaleric Acidemia (IVA) Treatment Market
14.1. South Korea Isovaleric Acidemia (IVA) Treatment Market Overview
14.2. South Korea Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Isovaleric Acidemia (IVA) Treatment Market
15.1. Western Europe Isovaleric Acidemia (IVA) Treatment Market Overview
15.2. Western Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Isovaleric Acidemia (IVA) Treatment Market
16.1. UK Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Isovaleric Acidemia (IVA) Treatment Market
18.1. France Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market
21.1. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market Overview
21.2. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Isovaleric Acidemia (IVA) Treatment Market
22.1. Russia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Isovaleric Acidemia (IVA) Treatment Market
23.1. North America Isovaleric Acidemia (IVA) Treatment Market Overview
23.2. North America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Isovaleric Acidemia (IVA) Treatment Market
24.1. USA Isovaleric Acidemia (IVA) Treatment Market Overview
24.2. USA Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Isovaleric Acidemia (IVA) Treatment Market
26.1. South America Isovaleric Acidemia (IVA) Treatment Market Overview
26.2. South America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Isovaleric Acidemia (IVA) Treatment Market
27.1. Brazil Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Isovaleric Acidemia (IVA) Treatment Market
28.1. Middle East Isovaleric Acidemia (IVA) Treatment Market Overview
28.2. Middle East Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Isovaleric Acidemia (IVA) Treatment Market
29.1. Africa Isovaleric Acidemia (IVA) Treatment Market Overview
29.2. Africa Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Isovaleric Acidemia (IVA) Treatment Market Competitive Landscape And Company Profiles
